Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Legend Biotech Corporation ( (LEGN) ) has released its Q3 earnings. Here is a breakdown of the information Legend Biotech Corporation presented ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Neurogene (NASDAQ: NGNE) stock just took a sharp dive, plummeting 44% in a single day. Bad news on Monday caused the ...

Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related to its ...

Shares of the U.S. biotech firm fell 3% to $8.73. The U.S. vaccine maker now expects between $175 million and $225 million ...

Biotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 ...

Tagrisso sales were up 14% to $1.67 billion (17% at CER), Calquence ... marking one of the most extensive scandals in China’s ...

Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...

It is expected to rise at a compound annual growth rate of 10% in US dollar terms. South Korea's pharmaceutical sales are ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Spero Therapeutics Inc. is pulling the plug on a lung disease drug trial and reducing its workforce by 39%. The Cambridge ...